AI and the Future of EIS and VCT Investing
Calculus explores how AI is reshaping EIS and VCT investing — from insurance underwriting to crop science — and what it means for tax-efficient portfolios.
Calculus explores how AI is reshaping EIS and VCT investing — from insurance underwriting to crop science — and what it means for tax-efficient portfolios.
Resurrect Bio is a biotechnology company revolutionising agriculture by equipping crops with genetic defenses against disease.
The IHT Landscape: Why Planning Has Never Mattered More
Calculus has made a follow-on investment in Optalitix, an award-winning technology company delivering low-code SaaS platforms, advanced data analytics, and AI-driven modelling solutions to insurers and financial institutions.
This is OBT’s third major pharma collaboration within the past 12 months and reflects strong validation of the OGAP®-Verify platform’s potential to drive oncology innovation.
The data shows complete tumour eradication and durable protection in a state-of-the-art aggressive brain cancer model that closely mimics human glioblastoma (GBM).
Resurrect Bio has announced a joint development agreement to tackle some of the most economically devastating diseases currently affecting corn production in the United States.